NeuroPace (NPCE) Stock Highlights

9.19 | +0.11%

2024-11-21 05:21:16

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.

Statistics

Range Today

8.63 9.33

Volume Today 25.8K

Range 1 Year

5.45 18.15

Volume 1 Year 24.38M

Range 3 Year

1.22 18.15

Volume 3 Year 51.87M

Range 10 Year

1.22 27.38

Volume 10 Year 69.41M

Highlights

Market Capitalization 219.27M (small)

Floating Shares 10.96M

Current Price 9.19

Price To Earnings -7.11

Price To Revenue 3.31

Price To Book 22.15

Earnings Per Share -1.07

Payout Ratio 0%

Performance

Latest +0.11%

1 Month +45.64%

3 Months +30.35%

6 Months +12.62%

1 Year +5.27%

3 Years -23.29%

5 Years -60.47%

10 Years -60.47%

Benchmarks

Market Capitalization

53 / 92

Gross Profits

58 / 85

Total Revenue

62 / 89

Total Rank

34 / 92

Free Cashflow

58 / 90

Performance 5 years

60 / 92

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.